14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.01 $5.38 Friday, 3rd May 2024 NEXI stock ended at $3.32. This is 6.41% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.58% from a day low at $3.10 to a day high of $3.49.
90 days $3.01 $11.90
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
Nov 02, 2023 $3.62 $3.72 $3.62 $3.72 1 988
Nov 01, 2023 $3.63 $3.63 $3.63 $3.63 502
Oct 31, 2023 $3.62 $3.91 $3.60 $3.72 5 318
Oct 30, 2023 $4.12 $4.13 $3.50 $3.88 10 410
Oct 27, 2023 $4.11 $4.16 $4.10 $4.14 7 256
Oct 26, 2023 $4.04 $4.18 $4.04 $4.14 7 026
Oct 25, 2023 $4.15 $4.28 $4.11 $4.28 5 057
Oct 24, 2023 $4.31 $4.31 $4.04 $4.12 17 788
Oct 23, 2023 $3.97 $4.15 $3.91 $4.07 13 968
Oct 20, 2023 $3.52 $4.39 $3.41 $4.13 50 012
Oct 19, 2023 $4.18 $4.37 $3.50 $3.58 32 335
Oct 18, 2023 $0.230 $0.239 $0.171 $0.179 613 723
Oct 17, 2023 $0.214 $0.230 $0.200 $0.221 75 210
Oct 16, 2023 $0.220 $0.220 $0.190 $0.205 238 247
Oct 13, 2023 $0.190 $0.224 $0.190 $0.190 55 822
Oct 12, 2023 $0.230 $0.230 $0.200 $0.200 66 506
Oct 11, 2023 $0.187 $0.222 $0.160 $0.210 231 283
Oct 10, 2023 $0.180 $0.189 $0.172 $0.180 16 655
Oct 09, 2023 $0.199 $0.199 $0.150 $0.180 44 576
Oct 06, 2023 $0.182 $0.194 $0.170 $0.185 34 256
Oct 05, 2023 $0.170 $0.196 $0.170 $0.176 22 749
Oct 04, 2023 $0.197 $0.197 $0.172 $0.180 118 956
Oct 03, 2023 $0.203 $0.206 $0.190 $0.197 95 471
Oct 02, 2023 $0.230 $0.230 $0.200 $0.209 28 468
Sep 29, 2023 $0.210 $0.210 $0.200 $0.210 21 903
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT